Skip to content

Visualization in Shoulder Arthroscopy With and Without Epinephrine

Surgeon Determined Visualization in Shoulder Arthroscopy: A Randomized, Blinded, Controlled Trial Comparing Irrigation Fluid With and Without Epinephrine

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01973699
Enrollment
83
Registered
2013-10-31
Start date
2012-11-30
Completion date
2013-08-31
Last updated
2016-01-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visualization in Shoulder Arthroscopy

Keywords

shoulder arthroscopy, epinephrine, visualization

Brief summary

Adequate visualization during shoulder arthroscopy is of great importance for the procedure to be efficiently and effectively performed. The use of dilute epinephrine in irrigation fluid has been historically utilized to help with visualization. Given the potential safety issues documented in the literature related to epinephrine use, as well as the significant improvements in technique and instrumentation over the last decade, the need for this additive should be reexamined. The objective of the current study was to compare surgeon determined visualization in shoulder arthroscopy using irrigation fluid with and without epinephrine.

Interventions

OTHERvisualization in shoulder arthroscopy

Evaluating the effect of performing shoulder arthroscopy with and without epinephrine on visualization

Sponsors

St. Luke's Hospital, Pennsylvania
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

All patients requiring shoulder arthroscopy

Exclusion criteria

none

Design outcomes

Primary

MeasureTime frameDescription
VisualizationNovember 1, 2012- April 1, 2013 (5 months)surgeon determined visualization during shoulder arthroscopy as judged by a VAS

Secondary

MeasureTime frameDescription
Fluid UseNovember 1, 2012-April 1, 2013 (5 months)fluid used during arthroscopy
Operative timeNovember 1, 2012-April 1, 2013 (5 months)operative time

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026